1 |
World Health Organization. 2017. Global Hepatitis Report 2017. Geneva: World Health Organization, 2017.
|
2 |
Kim DY, Kim IH, Jeong SH, Cho YK, Lee JH, Jin YJ, et al. 2013. A nationwide seroepidemiology of hepatitis C virus infection in South Korea. Liver Int. 33: 586-594.
DOI
|
3 |
Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359-362.
DOI
|
4 |
Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. 2005. Virus taxonomy: VIIIth report of the International Committee on Taxonomy of Viruses. Academic Press, Cambridge, USA.
|
5 |
Borgia SM, Hedskog C, Parhy B, Hyland RH, Stamm LM, Brainard DM, et al. 2018. Identification of a novel hepatitis C virus genotype from Punjab, India: expanding classification of hepatitis C virus into 8 genotypes. J. Infect. Dis. 218: 1722-1729.
DOI
|
6 |
Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. 2014. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 59: 318-327.
DOI
|
7 |
Simmonds P. 1997. Clinical relevance of hepatitis C virus genotypes. Gut 40: 291.
|
8 |
Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, et al. 2015. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61: 77-87.
DOI
|
9 |
Kim BH, Park J-W. 2018. Epidemiology of liver cancer in South Korea. Clin. Mol. Hepatol. 24: 1-9.
DOI
|
10 |
Petruzziello A, Marigliano S, Loquercio G, Coppola N, Piccirillo M, Leongito M, et al. 2017. Hepatitis C Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective study. Infect. Agents Cancer 12: 52.
|
11 |
Raimondi S, Bruno S, Mondelli MU, Maisonneuve P. 2009. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J. Hepatol. 50: 1142-1154.
DOI
|
12 |
Bruno S, Crosignani A, Maisonneuve P, Rossi S, Silini E, Mondelli MU. 2007. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology 46: 1350-1356.
DOI
|
13 |
Han CJ, Lee H-S, Kim H-S, Choe JH, Kim CY. 1997. Hepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases. Korean J. Intern. Med. 12: 21.
|
14 |
Seong MH, Kil H, Kim JY, Lee SS, Jang ES, Kim J-W, et al. 2013. Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6. Clin. Mol. Hepatol. 19: 45-50.
DOI
|
15 |
Lee H, Cho YK, Kim HU, Choi EK, Hyun S, Kang D, et al. 2008. Distribution of hepatitis C virus genotypes in Jeju Island. Korean J. Hepatol. 14: 28-35.
DOI
|
16 |
Waheed Y, Siddiq M, Jamil Z, Najmi MH. 2018. Hepatitis elimination by 2030: progress and challenges. World J. Gastroenterol. 24: 4959-4961.
DOI
|
17 |
Geddawy A, Ibrahim YF, Elbahie NM, Ibrahim MA. 2017. Direct acting anti-hepatitis C virus drugs: clinical pharmacology and future direction. J. Transl. Int. Med. 5: 8-17.
DOI
|
18 |
Jeong S-H, Jang ES, Choi HY, Kim K-A, Chung W, Ki M. 2017. Current status of hepatitis C virus infection and countermeasures in South Korea. Epidemiol. Health 39: e2017017.
|
19 |
Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, et al. 2011. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int. 31: 30-60.
DOI
|
20 |
Greene W, Cheong M, Ng V, Yap K. 1995. Prevalence of hepatitis C virus sequence variants in South-East Asia. J. Gen. Virol. 76: 211-215.
DOI
|
21 |
Li C, Yuan M, Lu L, Lu T, Xia W, Pham VH, et al. 2014. The genetic diversity and evolutionary history of hepatitis C virus in Vietnam. Virology 468: 197-206.
DOI
|
22 |
Wasitthankasem R, Vongpunsawad S, Siripon N, Suya C, Chulothok P, Chaiear K, et al. 2015. Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia. PLoS One 10: e0126764.
|
23 |
Nouhin J, Iwamoto M, Prak S, Dousset J-P, Phon K, Heng S, et al. 2019. Molecular epidemiology of hepatitis C virus in Cambodia during 2016-2017. Sci. Rep. 9: 7314.
|
24 |
Baatarkhuu O, Kim DY, Ahn SH, Nymadawa P, Dahgwahdorj Y, Shagdarsuren M, et al. 2008. Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study. Liver Int. 28: 1389-1395.
DOI
|
25 |
Assih M, Ouattara AK, Diarra B, Yonli AT, Compaore TR, ObiriYeboah D, et al. 2018. Genetic diversity of hepatitis viruses in West-African countries from 1996 to 2018. World J. Hepatol. 10: 807-821.
DOI
|
26 |
Chen Y, Yu C, Yin X, Guo X, Wu S, Hou J. 2017. Hepatitis C virus genotypes and subtypes circulating in Mainland China. Emerg. Microbes Infect. 6: e95.
|
27 |
Toyoda H, Kumada T, Takaguchi K, Shimada N, Tanaka J. 2014. Changes in hepatitis C virus genotype distribution in Japan. Epidemiol. Infect. 142: 2624-2628.
DOI
|
28 |
Lee C-M, Lu S-N, Hung C-H, Tung W-C, Wang J-H, Tung H-D, et al. 2006. Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications. Trans. R Soc. Trop. Med. Hyg. 100: 767-774.
DOI
|
29 |
Ho S-H, Ng K-P, Kaur H, Goh K-L. 2015. Genotype 3 is the predominant hepatitis C genotype in a multi-ethnic Asian population in Malaysia. Hepatobiliary Pancreat. Dis. Int. 14: 281-286.
DOI
|
30 |
Akkarathamrongsin S, Praianantathavorn K, Hacharoen N, Theamboonlers A, Tangkijvanich P, Tanaka Y, et al. 2010. Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand. J. Med. Virol. 82: 257-262.
DOI
|
31 |
Pybus OG, Barnes E, Taggart R, Lemey P, Markov PV, Rasachak B, et al. 2009. Genetic history of hepatitis C virus in East Asia. J. Virol. 83: 1071.
|
32 |
Chao D, Abe K, Nguyen M. 2011. Systematic review: epidemiology of hepatitis C genotype 6 and its management. Aliment Pharmacol. Ther. 34: 286-296.
DOI
|
33 |
Chung Y-S, Choi J-Y, Han MG, Park KR, Park S-J, Lee H, et al. 2018. A large healthcare-associated outbreak of hepatitis C virus genotype 1a in a clinic in Korea. J. Clin. Virol. 106: 53-57.
DOI
|
34 |
Wyles D, Luetkemeyer A. 2017. Understanding hepatitis C virus drug resistance: clinical implications for current and future regimens. Top. Antivir. Med. 25: 103-109.
|
35 |
Kan T, Hashimoto S, Kawabe N, Murao M, Nakano T, Shimazaki H, et al. 2016. The clinical features of patients with a Y93H variant of hepatitis C virus detected by a PCR invader assay. J. Gastroenterol. 51: 63-70.
DOI
|
36 |
Hong C-M, Lin Y-Y, Liu C-J, Lai Y-Y, Yeh S-H, Yang H-C, et al. 2021. Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan. Viruses 13: 2294.
|